(2-246) Beyond Endocrine Therapy: Datopotamab Deruxtecan vs Chemotherapy in Metastatic HR-Positive/HER2-Negative Breast Cancer

Monday, December 8, 2025

10:45 AM - 11:45 AM

Location: Bayside A, Level 1

Pharmacy School: Nova Southeastern University Barry and Judy Silverman College of Pharmacy
Pharmacy School Location: Florida

Co-Author(s): Mariam Gonzalez, Mitra Esfahani Zadeh, Marielis Gonzalez Gonzalez, Huy Pham

Primary Author(s)

Daylen Camacho Torres, PharmD Candidate

Pharmacy Student
Nova Southeastern University